Week of July 2, 2024 | Vol. 13, Issue 27

In This Issue

Upcoming Events

Industry Activity

Market Research

M&A Pipeline

Featured Headlines

Recent Transactions

Contact

Xan Smith

Managing Director, Private Equity Coverage & Origination


Jeremy C. Johnson

Senior Managing Director, Head of Investment Banking

About
Research

Industry Snapshot

Upcoming Events

Let's Meet!

Industry Activity

M&A Transactions

Pharma & Biotech

10 transactions totaling $1,861 million


Supplies, Equipment & Services

15 transactions totaling $89 million


Healthcare Facilities & Distributors

6 transactions totaling $479 million


Healthcare IT & Managed Care

2 transactions totaling $56 million

Featured Chart

Global Demand for Cosmetic Oils Set to be a Driver of the Broader Personal Care and Wellness Space

Source: Technavio

Trading Comps

Market Research

Bourne Brief

BIO 2024 & Pending BIOSECURE Act


5 Drivers of the PRV Market


Navigating Tailwinds & Headwinds in Clinical Research Service


Capital Markets Update

2024 Outlook


Market Insight

Biostorage Services Report

More Research

M&A Pipeline

For more information about our active deals, please reach out to the following:

Pharmaceuticals



Robert Stanley

Director

Carson Riley

Vice President

Pharma Services



Todd Bokus

Director

Jake Curtis

Vice President

Healthcare & Pharmacy Services

Aaron Olson

Managing Director, Head of Healthcare Services

Featured Headlines

FDA publishes updated draft guidance on clinical trial diversity

Fierce Biotech

Thermo Fisher Scientific Expands Clinical Research Laboratory in Kentucky

Thermo Fisher

IDT Biologika and SK bioscience enter a strategic partnership

Bora Pharmaceuticals

Veranova Announces New Investment to Expand ADC and Highly Potent API Capabilities at Devens, MA, Facility

Veranova

Novo Nordisk announces 4.1 billion USD investment to expand US manufacturing capacity

Novo Nordisk

Wacker and CordenPharma Enter Pandemic Readiness

Contract Pharma

Recent Transactions

Bourne continues to be one of the most active Pharma Services Advisors, having closed 7 transactions with 7 different sponsors within the last 45 days with more to come! Select recent clients and counterparties include:

LinkedIn  Web